TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 46 filers reported holding TFF PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,768 | -25.5% | 145,050 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $68,174 | -35.9% | 145,050 | -6.5% | 0.00% | -50.0% |
Q1 2023 | $106,352 | +0.4% | 155,191 | +53.8% | 0.00% | 0.0% |
Q4 2022 | $105,936 | -66.0% | 100,891 | +31.2% | 0.00% | -66.7% |
Q3 2022 | $312,000 | -27.9% | 76,891 | +0.4% | 0.01% | -20.0% |
Q2 2022 | $433,000 | -9.8% | 76,591 | +0.7% | 0.02% | +7.1% |
Q1 2022 | $480,000 | -29.3% | 76,091 | -0.5% | 0.01% | -26.3% |
Q4 2021 | $679,000 | +15.9% | 76,500 | +0.8% | 0.02% | +5.6% |
Q3 2021 | $586,000 | -15.2% | 75,900 | +5.5% | 0.02% | -14.3% |
Q2 2021 | $691,000 | -25.0% | 71,950 | +6.0% | 0.02% | -27.6% |
Q1 2021 | $921,000 | -26.0% | 67,900 | -21.9% | 0.03% | -31.0% |
Q4 2020 | $1,244,000 | -22.7% | 86,900 | -0.2% | 0.04% | -34.4% |
Q3 2020 | $1,609,000 | +196.9% | 87,100 | -7.5% | 0.06% | +166.7% |
Q2 2020 | $542,000 | +57.6% | 94,150 | +5.1% | 0.02% | +20.0% |
Q1 2020 | $344,000 | +514.3% | 89,550 | +752.9% | 0.02% | +900.0% |
Q4 2019 | $56,000 | – | 10,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,565,682 | $21,246,000 | 7.82% |
APIS CAPITAL ADVISORS, LLC | 182,500 | $2,477,000 | 2.25% |
Altium Capital Management LP | 269,691 | $3,660,000 | 1.02% |
Mesirow Financial Investment Management, Inc. | 27,216 | $369,000 | 1.00% |
PRECEPT MANAGEMENT LLC | 107,300 | $1,456,000 | 0.99% |
Gagnon Advisors, LLC | 176,471 | $2,395,000 | 0.99% |
GAGNON SECURITIES LLC | 377,976 | $5,129,000 | 0.78% |
P.A.W. CAPITAL CORP | 63,695 | $864,000 | 0.76% |
Diametric Capital, LP | 32,868 | $446,000 | 0.34% |
DRW Securities, LLC | 513,400 | $6,967,000 | 0.28% |